Outcomes after <scp>SynCardia</scp>® temporary total artificial heart implantation: A 20‐year single‐center experience in 196 patients
While high mortality rates persist among patients with biventricular failure, the SynCardia® TAH offers a viable interim solution for critically ill patients, particularly those who can be successfully bridged to heart transplantation.
Authors
- Henrik Fox (ORCID: https://orcid.org/0000-0002-2187-8715)
- Jan Fritz Gummert (ORCID: https://orcid.org/0000-0002-6956-9110)
- Sebastián V. Rojas (ORCID: https://orcid.org/0000-0002-9505-1358)
- Michiel Morshuis (ORCID: https://orcid.org/0000-0002-6178-5791)
- Armin Zittermann (ORCID: https://orcid.org/0000-0001-6085-6554)
- Volker Lauenroth
- René Schramm (ORCID: https://orcid.org/0000-0001-5803-3575)
- Artyom Razumov (ORCID: https://orcid.org/0009-0009-5782-7977)
- Melchior Burri (ORCID: https://orcid.org/0000-0002-8540-7090)
- Darko Radakovic (ORCID: https://orcid.org/0000-0002-3380-0747)
- M Deutsch
Institutions
- Heart and Diabetes Center North Rhine-Westphalia (DE)
- Deutsches Herzzentrum München (DE)
- Technical University of Munich (DE)
Publication Details
- Journal
- Artificial Organs
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1111/aor.14860
- Citations
- 8
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 1.48